242 related articles for article (PubMed ID: 21412127)
1. The cost of providing comprehensive HIV treatment in PEPFAR-supported programs.
Menzies NA; Berruti AA; Berzon R; Filler S; Ferris R; Ellerbrock TV; Blandford JM
AIDS; 2011 Sep; 25(14):1753-60. PubMed ID: 21412127
[TBL] [Abstract][Full Text] [Related]
2. The determinants of HIV treatment costs in resource limited settings.
Menzies NA; Berruti AA; Blandford JM
PLoS One; 2012; 7(11):e48726. PubMed ID: 23144946
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of HIV care and treatment in PEPFAR-supported sites.
Filler SJ; Berruti AA; Menzies N; Berzon R; Ellerbrock TV; Ferris R; Blandford JM
J Acquir Immune Defic Syndr; 2011 May; 57(1):e1-6. PubMed ID: 21346585
[TBL] [Abstract][Full Text] [Related]
4. Costing analysis of national HIV treatment and care program in Vietnam.
Duong AT; Kato M; Bales S; Do NT; Minh Nguyen TT; Thanh Cao TT; Nguyen LT
J Acquir Immune Defic Syndr; 2014 Jan; 65(1):e1-7. PubMed ID: 23846564
[TBL] [Abstract][Full Text] [Related]
5. Expansion of HIV-1 screening and anti-retroviral treatment programs in a resource-poor setting: results from a faith-based organization in Jos, Plateau State, Nigeria.
Lum H; Isichei C; Isichei-Wakili M; Redfield R
Afr Health Sci; 2007 Jun; 7(2):93-100. PubMed ID: 17594286
[TBL] [Abstract][Full Text] [Related]
6. Annual cost of antiretroviral therapy among three service delivery models in Uganda.
Vu L; Waliggo S; Zieman B; Jani N; Buzaalirwa L; Okoboi S; Okal J; Borse NN; Kalibala S
J Int AIDS Soc; 2016; 19(5 Suppl 4):20840. PubMed ID: 27443270
[TBL] [Abstract][Full Text] [Related]
7. Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia.
Tagar E; Sundaram M; Condliffe K; Matatiyo B; Chimbwandira F; Chilima B; Mwanamanga R; Moyo C; Chitah BM; Nyemazi JP; Assefa Y; Pillay Y; Mayer S; Shear L; Dain M; Hurley R; Kumar R; McCarthy T; Batra P; Gwinnell D; Diamond S; Over M
PLoS One; 2014; 9(11):e108304. PubMed ID: 25389777
[TBL] [Abstract][Full Text] [Related]
8. Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort study.
Scott CA; Iyer HS; McCoy K; Moyo C; Long L; Larson BA; Rosen S
BMC Public Health; 2014 Mar; 14():296. PubMed ID: 24684772
[TBL] [Abstract][Full Text] [Related]
9. Effect of PEPFAR funding policy change on HIV service delivery in a large HIV care and treatment network in Nigeria.
Banigbe B; Audet CM; Okonkwo P; Arije OO; Bassi E; Clouse K; Simmons M; Aliyu MH; Freedberg KA; Ahonkhai AA
PLoS One; 2019; 14(9):e0221809. PubMed ID: 31553735
[TBL] [Abstract][Full Text] [Related]
10. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda.
Jain V; Chang W; Byonanebye DM; Owaraganise A; Twinomuhwezi E; Amanyire G; Black D; Marseille E; Kamya MR; Havlir DV; Kahn JG
PLoS One; 2015; 10(12):e0143433. PubMed ID: 26632823
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe.
Medina Lara A; Kigozi J; Amurwon J; Muchabaiwa L; Nyanzi Wakaholi B; Mujica Mota RE; Walker AS; Kasirye R; Ssali F; Reid A; Grosskurth H; Babiker AG; Kityo C; Katabira E; Munderi P; Mugyenyi P; Hakim J; Darbyshire J; Gibb DM; Gilks CF;
PLoS One; 2012; 7(4):e33672. PubMed ID: 22545079
[TBL] [Abstract][Full Text] [Related]
12. Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults.
Sloan CE; Champenois K; Choisy P; Losina E; Walensky RP; Schackman BR; Ajana F; Melliez H; Paltiel AD; Freedberg KA; Yazdanpanah Y;
AIDS; 2012 Jan; 26(1):45-56. PubMed ID: 22008655
[TBL] [Abstract][Full Text] [Related]
13. Treatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa.
Long LC; Rosen SB; Brennan A; Moyo F; Sauls C; Evans D; Modi SL; Sanne I; Fox MP
PLoS One; 2016; 11(12):e0168118. PubMed ID: 27942005
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact and cost of monitoring for asymptomatic laboratory abnormalities among patients receiving antiretroviral therapy in a resource-poor setting.
Koenig SP; Schackman BR; Riviere C; Leger P; Charles M; Severe P; Lastimoso C; Colucci N; Pape JW; Fitzgerald DW
Clin Infect Dis; 2010 Sep; 51(5):600-8. PubMed ID: 20649436
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.
Losina E; Touré H; Uhler LM; Anglaret X; Paltiel AD; Balestre E; Walensky RP; Messou E; Weinstein MC; Dabis F; Freedberg KA; ;
PLoS Med; 2009 Oct; 6(10):e1000173. PubMed ID: 19859538
[TBL] [Abstract][Full Text] [Related]
16. ART treatment costs and retention in care in Kenya: a cohort study in three rural outpatient clinics.
Larson BA; Bii M; Henly-Thomas S; McCoy K; Sawe F; Shaffer D; Rosen S
J Int AIDS Soc; 2013 Jan; 16(1):18026. PubMed ID: 23305696
[TBL] [Abstract][Full Text] [Related]
17. Alternative financing mechanisms for ART programs in health facilities in Uganda: a mixed-methods approach.
Zakumumpa H; Bennett S; Ssengooba F
BMC Health Serv Res; 2017 Jan; 17(1):65. PubMed ID: 28114932
[TBL] [Abstract][Full Text] [Related]
18. Efficiency of HIV services in Nigeria: Determinants of unit cost variation of HIV counseling and testing and prevention of mother-to-child transmission interventions.
Bautista-Arredondo S; La Hera-Fuentes G; Contreras-Loya D; Kwan A; Van Buren SJ; Amanze OO; Atobatele A; Adeyemi A; Abatta E; Ogungbemi KM; Sosa-Rubí SG
PLoS One; 2018; 13(9):e0201706. PubMed ID: 30192765
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of differentiated service delivery models for HIV treatment in Lesotho: costs to providers and patients.
Nichols BE; Cele R; Lekodeba N; Tukei B; Ngorima-Mabhena N; Tiam A; Maotoe T; Sejana MV; Faturiyele IO; Chasela C; Rosen S; Fatti G
J Int AIDS Soc; 2021 Apr; 24(4):e25692. PubMed ID: 33838012
[TBL] [Abstract][Full Text] [Related]
20. Redefining and revisiting cost estimates of routine ART care in Zambia: an analysis of ten clinics.
Tucker A; Tembo T; Tampi RP; Mutale J; Mukumba-Mwenechanya M; Sharma A; Dowdy DW; Moore CB; Geng E; Holmes CB; Sikazwe I; Sohn H
J Int AIDS Soc; 2020 Feb; 23(2):e25431. PubMed ID: 32064766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
